General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Details Narrative)

v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
2 Months Ended 6 Months Ended
May 25, 2018
Mar. 19, 2018
Oct. 04, 2017
Jun. 29, 2018
Jun. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Number of shares acquired in exchange for common stock     31,745,242   2,090,301    
Precentage of issued and outstanding common stock diluted basis     90.00%        
Common stock issued         38,674,265 35,272,626 31,745,242
Common stock shares outstanding         38,674,265 35,272,626 31,745,242
Recognization of license intangible asset         8,000,000    
Additional Paid-In Capital [Member]              
Recognization of license intangible asset         8,000,000    
CoNCERT Pharmaceuticals, Inc [Member]              
Common stock and a warrant purchase price per share   $ 3.83          
Option exercised in exchange for common stock   $ 8,000,000          
Number of shares acquired in exchange for common stock   2,090,301          
Percentage of common stock holdings   6.58%          
Precentage of issued and outstanding common stock diluted basis   5.93%          
Common stock issued   35,272,626          
Common stock shares outstanding   35,272,626          
Controlling interest, description   Promet's controlling interest was reduced from 90% to 84%.          
CoNCERT Pharmaceuticals, Inc [Member] | Additional Paid-In Capital [Member]              
Recognization of license intangible asset         8,000,000    
2018 Private Placement Transactions [Member]              
Number of units sold       1,402,442      
Purchase price per unit       $ 2.27      
Gross proceeds from unit sold       $ 3,200,000      
Common stock and a warrant purchase price per share       $ 2.724      
Amount paid to placement agent       $ 167,526      
Issued placement agent warrants to purchase shares       84,146      
Warrants term       3 years      
Notes receivable       $ 107,490      
PoC Capital, LLC [Member]              
Number of units sold 792,952            
Purchase price per unit $ 2.724            
Common stock and a warrant purchase price per share $ 2.724            
Warrant expiry date Jul. 29, 2021            
Amount paid to placement agent $ 108,000            
Issued placement agent warrants to purchase shares 47,578            
Warrants term 3 years            
Amount financed under agreement $ 1,800,000            
Pledge Agreement with PoC [Member]              
Number of units sold 396,476            
Purchase price per unit $ 2.27            
Gross proceeds from unit sold $ 20,000,000            
Common stock and a warrant purchase price per share $ 0.01            
Amount paid to placement agent $ 720,000            
Pledge Agreement with PoC [Member] | First Tranche [Member]              
Number of units sold 198,238            
Pledge Agreement with PoC [Member] | Second Tranche [Member]              
Number of units sold 198,238